Magnetic nanoparticles break the capacity barrier for antibody purification

Aug 13, 2014
Magnetic nanoparticles break the capacity barrier for antibody purification
A novel separation technique uses starch-coated magnetic nanoparticles (green) and polyethylene glycol to purify monoclonal antibodies (blue). Credit: © 2013 Elsevier

Monoclonal antibodies represent the largest and fastest-growing segment of international biopharma. While these therapeutic agents are a boon for global healthcare, productivity constraints pose a serious challenge for manufacturers seeking to make sufficient amounts for therapeutic applications. Now, A*STAR researchers have developed a high-capacity method to purify monoclonal antibodies that uses magnetic nanoparticles and also introduces new operating conditions.

At present, are generally purified by a technique known as protein A affinity chromatography. The process yields a high purification factor—typically 99 per cent—but it is slow, thereby creating a severe productivity bottleneck. The process is largely hindered by the low capacity of protein A, which binds at an average rate of 50 grams per liter of protein A chromatography media. The overall purification process requires unpurified antibodies to pass through columns packed with the media in multiple cycles that can take up to a week.

A research team led by Pete Gagnon and co-workers from the A*STAR Bioprocessing Technology Institute in Singapore have developed an alternative method with 1,000 times the capacity of protein A. The technique involves the use of polyethylene glycol, which causes the antibodies to be deposited on the surface of starch-coated (see image). The particles are collected in a magnetic field, undeposited contaminants are washed away and the purified antibodies recovered by removing the .

"The high capacity of our nanoparticle method makes it much faster than column chromatography," explains Gagnon. "Instead of the pharmaceutical industry norm of five to eight cycles, the new process requires only one cycle, which takes just a few hours." This reduction dramatically increases the productivity of the new approach over traditional methods.

The new method also required the research team to develop new operating conditions. Polyethylene glycol has been used for decades to process antibodies, but it has never achieved the level of purity needed for clinical therapeutics. The team discovered that by elevating the salt concentration, they could reduce contaminant levels from about 250,000 parts per million to 500: the same level achieved by protein A. A single follow-on polishing step using a multimodal chromatography column further purified the antibodies to clinical quality standards.

Gagnon notes the high potential for adoption of the new technology by industry. In addition to solving the long-standing problem of productivity for monoclonal , the nanoparticle approach can be applied to many other therapeutic proteins and also to viral vaccines.

Explore further: New method provides researchers with efficient tool for tagging proteins

More information: Gagnon, P., Toh, P. & Lee, J. High productivity purification of immunoglobulin G monoclonal antibodies on starch-coated magnetic nanoparticles by steric exclusion of polyethylene glycol. Journal of Chromatography A 1324, 171–180 (2013). dx.doi.org/10.1016/j.chroma.2013.11.039

add to favorites email to friend print save as pdf

Related Stories

Food allergies: A new, simple method to track down allergens

Jul 02, 2014

Although food allergies are common, sufferers often don't know exactly what in foods cause their allergic reactions. This knowledge could help develop customized therapies, like training the body's immune system to respond ...

Recommended for you

Molecular beacons shine light on how cells 'crawl'

1 hour ago

Adherent cells, the kind that form the architecture of all multi-cellular organisms, are mechanically engineered with precise forces that allow them to move around and stick to things. Proteins called integrin ...

User comments : 0